In view of the assembly of evidences uncovering aberrances of JAK/STAT signaling in multiple forms of human cancers, here we focused on the potential linkage between TRIM66 and the JAK/STAT pathway in prostate cancer. Here, TRIM66 is linked to prostate carcinoma.